Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways
Yanshu Li, 1–3 Shiheng Jia, 3, 4 Wei Dai 5, 6 1Key Laboratory of Cell Biology, Ministry of Public Health, China Medical University, Shenyang, Liaoning, People’s Republic of China; 2Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang...
Main Authors: | Li Y, Jia S, Dai W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-02-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/fisetin-modulates-human-oral-squamous-cell-carcinoma-proliferation-by--peer-reviewed-article-DDDT |
Similar Items
-
Regulatory Effects of Fisetin on Microglial Activation
by: Jing-Yuan Chuang, et al.
Published: (2014-06-01) -
Estimation of Fisetin in Strawberry (Fragaria ananassa) by UV-Vis Spectrophotometry
by: Subhadip Chakraborty, et al.
Published: (2024-03-01) -
Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics
by: Rachna M. Kumar, et al.
Published: (2023-01-01) -
Oral administration of fisetin promotes the induction of hippocampal long-term potentiation in vivo
by: Wen-bin He, et al.
Published: (2018-01-01) -
Nrf2–ARE Signaling Acts as Master Pathway for the Cellular Antioxidant Activity of Fisetin
by: Huihui Zhang, et al.
Published: (2019-02-01)